Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials | Zendy

Fernando Moya | Zendy

Open Access

Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials

Author(s) -

Fernando Moya

Publication year - 2009

Publication title -

therapeutics and clinical risk management

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.719

H-Index - 55

eISSN - 1178-203X

pISSN - 1176-6336

DOI - 10.2147/tcrm.s4029

Subject(s) - medicine , clinical trial , pulmonary surfactant , neonatal respiratory distress syndrome , respiratory distress , intensive care medicine , surgery , biology , gestational age , pregnancy , biochemistry , genetics

Available literature suggests that the advantage of animal-derived surfactants over first-generation synthetic agents derives from the presence of surface-active proteins and their phospholipid content. Here we summarize the results of clinical trials comparing animal-derived surfactant preparations with other animal-derived surfactants and with both first-and second-generation synthetic surfactants.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research